In review of the drug list high-cost serious illnesses for which electronic pre-authorization is required, Mr EOPYY with the addition of 15 more formulations.
As mentioned, the list includes 98 products in total, while the 15 new ones are as follows:
CUFENCE (treatment of Wilson’s disease).
DARZALEX (for light chain amyloidosis).
DOPTELET (for severe thrombocytopenia in adult patients with chronic liver disease).
DUPIXENT (moderate to severe atopic dermatitis).
EMGALITY (migraine prophylaxis).
EVENITY (severe osteoporosis in postmenopausal women at high risk of fracture).
LUXTURNA (vision loss due to hereditary retinal dystrophy).
NEXOBRID (eschar removal in adults with deep partial and full thickness thermal burns).
OLUMIANT (atopic dermatitis).
REBLOZYL (transfusion-dependent anemia due to myelodysplastic syndromes).
RINVOQ (atopic dermatitis).
TEGSEDI (stage 1 or stage 2 polyneuropathy in adult patients with hereditary transthyretin amyloidosis).
VYNDAQEL (treatment of transthyretin-related amyloidosis in adult patients with stage 1 symptomatic polyneuropathy and for the treatment of natural or hereditary transthyretin-related amyloidosis in adult patients with cardiomyopathy (ATTR-CM)).
ZEJULA (ovarian, fallopian tube or primary peritoneal cancer).
ZOLGENSMA (spinal muscular atrophy).
It is clarified that for all the indications of approved medicines on the positive list, for which no relevant ministerial decision has been issued to date to include them in the positive list of reimbursed medicines, a pre-approval procedure is required for their reimbursement.
Please note that for hepatitis C drugs on the list, requests are entered into the hepatitis C registry.
For the inclusion of the above medicines in the procedure, there is an agreement of the pharmaceutical expenditure monitoring committee.
RES-EMP
Read the News today and get the latest news.
Follow Skai.gr on Google News and be the first to know all the news.
I have worked in the news industry for over 10 years. I have a vast amount of experience in covering health news. I am also an author at News Bulletin 247. I am highly experienced and knowledgeable in this field. I am a hard worker and always deliver quality work. I am a reliable source of information and always provide accurate information.
